Addiction Statistics in US 2026 | Key Facts

Addiction in America 2026

Addiction is not a fringe issue confined to back alleys or broken families — it is a mainstream public health crisis woven into the fabric of everyday American life. According to the most recent data released by the Substance Abuse and Mental Health Services Administration (SAMHSA) in July 2025, 48.4 million people aged 12 or older — or 16.8% of the US population — met diagnostic criteria for a substance use disorder (SUD) in the past year. That is nearly 1 in 6 Americans. The 2024 National Survey on Drug Use and Health (NSDUH), the gold standard federal survey for behavioral health data, also found that 73.6 million people (25.5% of all Americans aged 12 or older) used illicit drugs in the past year, up from 22.2% in 2021. Marijuana remains the most used illicit substance at 64.2 million past-year users, while opioids, stimulants, and cocaine continue to claim tens of thousands of lives annually through overdose. Amid the devastation, 2024 also brought meaningful signs of progress: drug overdose deaths fell sharply — from 105,007 in 2023 to 79,384 in 2024, a nearly 27% decline confirmed by the CDC — marking the most significant year-over-year drop in overdose mortality in decades.

Yet the progress on overdose deaths does not close the treatment gap that has defined the US addiction crisis for generations. In 2024, 80% of people who needed substance use disorder treatment did not receive it. Of the estimated population classified as needing treatment, only about 1 in 5 — 19.3%, or 10.2 million people — actually got it. The reasons are layered: stigma, cost, lack of available providers, and, most commonly among those who recognize they have a problem, simply not feeling ready to change. Meanwhile, the mental health and addiction overlap is staggering — 21.2 million adults suffered from both a mental health disorder and a substance use disorder simultaneously in 2024, a co-occurring condition that makes treatment more complex and outcomes harder to achieve without integrated care. Whether you are a public health professional, a policymaker, a family member watching a loved one struggle, or simply someone trying to understand the full scope of what addiction means in America right now, the data in this article tells the most current, honest, and complete story available.

Key Facts: Addiction Statistics in the US 2026

 ADDICTION FAST FACTS — US 2024/2026
 ──────────────────────────────────────────────────────────────
  🧠 Americans with SUD (2024, age 12+)           48.4 Million
  📊 % of US population with SUD (2024)               16.8%
  🍺 Alcohol use disorder (2024)                  27.9 Million
  💊 Drug use disorder (2024)                     28.2 Million
  🌿 Marijuana use disorder (2024)                20.6 Million
  💉 Opioid use disorder (2024)                    4.8 Million
  💀 Drug overdose deaths (2024, final)               79,384
  💀 Estimated OD deaths (2025, provisional)          69,973
  🏥 People needing SUD treatment who got it (2024)   ~20%
  👥 Co-occurring SUD + mental illness (2024)     21.2 Million
 ──────────────────────────────────────────────────────────────

Source: SAMHSA 2024 National Survey on Drug Use and Health (NSDUH), released July 28, 2025; CDC National Vital Statistics System Provisional Drug Overdose Data, April 2026; CDC Drug Overdose Deaths in the United States 2023–2024 Data Brief; NIDA Drug Overdose Death Facts and Figures

The numbers above carry a weight that is difficult to hold in full view. Nearly 1 in 6 Americans aged 12 and older meets the clinical criteria for a substance use disorder right now — not substance use, not experimentation, but a diagnosable disorder as defined by the DSM-5. The 48.4 million figure for 2024 represents a meaningful increase from prior years: the drug use disorder rate among people 12 or older climbed from 8.7% in 2021 to 9.8% in 2024, while the alcohol use disorder rate showed a modest decline from 10.6% to 9.7% over the same period. The most striking headline from the CDC’s 2025 mortality data release is the historic drop in overdose deaths: from 105,007 in 2023 to 79,384 in 2024, a decrease of more than 25,600 lives saved in a single year — a genuinely unprecedented pace of decline. Provisional data for 2025 suggests the trend is continuing, with an estimated 70,231 overdose deaths in the 12 months ending November 2025, down another 15.9%. Yet even at 70,000+ deaths per year, drug overdose remains the leading cause of accidental death in America and the top cause of death for Americans aged 18–44, outpacing both car accidents and gun violence.

Substance Use Disorder (SUD) Prevalence Statistics in the US 2026

 SUD PREVALENCE BY TYPE — US 2024 (People Aged 12+)
 ──────────────────────────────────────────────────────────────
  Total SUD (any)              ██████████░░░░░░░░░░  48.4M (16.8%)
  Alcohol Use Disorder         ████████░░░░░░░░░░░░  27.9M ( 9.7%)
  Drug Use Disorder            ████████░░░░░░░░░░░░  28.2M ( 9.8%)
  Marijuana Use Disorder       ██████░░░░░░░░░░░░░░  20.6M ( 7.2%)
  Opioid Use Disorder          █░░░░░░░░░░░░░░░░░░░   4.8M ( 1.7%)
  CNS Stimulant Use Disorder   █░░░░░░░░░░░░░░░░░░░   4.3M ( 1.5%)
  Both AUD & DUD               █░░░░░░░░░░░░░░░░░░░   7.7M ( 2.7%)
 ──────────────────────────────────────────────────────────────
  Source: SAMHSA 2024 NSDUH, released July 28, 2025

Source: SAMHSA 2024 National Survey on Drug Use and Health (NSDUH); SAMHSA 2024 NSDUH Substance Use Disorder Treatment Month Proclamation 2026

Marijuana use disorder, at 20.6 million people, is by far the most prevalent drug use disorder in the United States, a figure that reflects both the ubiquity of cannabis use and the growing potency of modern cannabis products. The opioid use disorder figure of 4.8 million sits below marijuana but carries a disproportionate mortality burden — opioid-involved overdose deaths remain the single deadliest component of the overdose crisis, even as overall numbers have fallen dramatically. The CNS stimulant use disorder figure of 4.3 million captures methamphetamine, amphetamine, and prescription stimulant misuse combined, a category whose overdose death contribution is growing: in 2023, nearly 35,000 overdose deaths involved psychostimulants, with the majority also involving fentanyl.

The 10-year trend line tells two different stories depending on the substance. Drug use disorder rates are rising — from 8.7% in 2021 to 9.8% in 2024, driven substantially by marijuana disorder as cannabis becomes more legally and socially available nationwide. Alcohol use disorder rates are slightly falling — from 10.6% in 2021 to 9.7% in 2024 — a modest but genuine signal that the long-term cultural shift away from heavy drinking, particularly among younger cohorts, may be having a measurable population-level effect. But the most troubling number in this table is the 27.9% of adolescents who had both a major depressive episode and a substance use disorder and received no treatment at all in 2024 — a statistic that points directly at the failure of early intervention systems to reach the young people who most need them.

Drug Overdose Death Statistics in the US 2026

 DRUG OVERDOSE DEATHS — US TREND (Annual)
 ──────────────────────────────────────────────────────────────
  2019   ████████████░░░░░░░░░░░░░░░░░░░░   70,630
  2020   ████████████████░░░░░░░░░░░░░░░░   93,655
  2021   █████████████████████░░░░░░░░░░░  106,699
  2022   █████████████████████░░░░░░░░░░░  107,941
  2023   ████████████████████░░░░░░░░░░░░  105,007
  2024   ████████████░░░░░░░░░░░░░░░░░░░░   79,384  ↓ 26.8%
  2025*  ██████████░░░░░░░░░░░░░░░░░░░░░░   ~70,231  ↓ 15.9%
         * Provisional, 12 months ending Nov. 2025
 ──────────────────────────────────────────────────────────────
  Source: CDC NCHS National Vital Statistics System

Source: CDC NCHS Data Brief — Drug Overdose Deaths in the United States 2023–2024 (2025); CDC Newsroom, February 25, 2025 and May 14, 2025; CDC About Overdose Prevention, April 2026; NIDA Drug Overdose Death Facts and Figures; U.S. News & World Report, May 2026

The story of drug overdose deaths in the United States across 2023–2025 is one of history’s most dramatic public health inflection points. After more than two decades of near-continuous escalation — rising from 12,122 in 1999 to a horrifying peak of 107,941 in 2022 — overdose deaths reversed course with sudden, stunning force. The 26.8% decline from 2023 to 2024 translates to more than 25,000 additional Americans alive who would not have been under the prior trajectory. CDC’s framing that this represents “more than 81 lives saved every day” is not rhetorical flourish — it is what the math produces. The provisional 2025 data suggests the decline is continuing, with an estimated 70,231 deaths in the 12 months ending November 2025, a further 15.9% fall.

Fentanyl and other illicitly manufactured synthetic opioids remain the engine of the overdose epidemic even as their toll declines. In 2024, 68% of all overdose deaths involved opioids, and of those, 88% were attributable to fentanyl and synthetic opioids. The reach of fentanyl extends far beyond opioid use: nearly 47% of overdose deaths in 2023 involved both opioids and stimulants — meaning fentanyl-laced methamphetamine, cocaine, and counterfeit pills are killing people who may not even know they are consuming an opioid. Cocaine-involved deaths, at 29,449 in 2023, have risen 85% since 2019, almost entirely because of fentanyl contamination of the cocaine supply. The encouraging news is that 45 states showed overdose death declines in the most recent data period, with states like West Virginia, Ohio, and Virginia seeing drops of 35% or more — a geographic breadth that suggests system-level interventions (expanded naloxone access, medication-assisted treatment, harm reduction services) are working at scale.

Alcohol Addiction Statistics in the US 2026

 ALCOHOL USE DISORDER & BINGE DRINKING — US 2024
 ──────────────────────────────────────────────────────────────
  Alcohol Use Disorder (aged 12+)  ██████████░░░░░░░   27.9M (9.7%)
  Binge drinkers past month (12+)  ████████████░░░░░   57.9M (20.1%)
  Binge drinkers 18–25 age group   ████████░░░░░░░░░    9.3M (26.7%)
  Heavy drinkers past month (18+)  ███░░░░░░░░░░░░░░   16.1M ( 6.1%)
  Underage drinkers aged 12–20     ██░░░░░░░░░░░░░░░    5.1M (13.0%)
  Underage binge drinkers 12–20    █░░░░░░░░░░░░░░░░    0.9M ( 3.5%)
 ──────────────────────────────────────────────────────────────
  Source: SAMHSA 2024 NSDUH; NIAAA Alcohol Facts & Statistics 2025

Source: SAMHSA 2024 NSDUH (released July 2025); NIAAA Alcohol Facts and Statistics 2025; Responsibility.org Underage Drinking Statistics 2026; American Addiction Centers — Alcohol and Drug Abuse Statistics

Alcohol use disorder remains one of the most prevalent and socially underestimated forms of addiction in America, with 27.9 million people meeting clinical criteria for AUD in 2024. This figure sits at the intersection of ubiquitous legal availability, deep cultural normalization, and a disease process that is frequently invisible until it has already caused serious damage. The 57.9 million Americans who binge drink in any given month — nearly 1 in 5 people aged 12 or older — represent a massive pool of elevated risk, since binge drinking is both a risk factor for developing AUD and, in itself, a behavior that causes acute harms ranging from accidents and injuries to alcohol poisoning. Young adults aged 18 to 25 binge drink at the highest rate — 26.7% — a figure that has actually been declining since 2021 but remains alarmingly high in a demographic that is simultaneously at peak brain development vulnerability.

The intergenerational data is among the most important in this table. Adults who first drank before age 15 are 6.5 times more likely to develop an alcohol use disorder than those who did not drink before age 21 — a statistic that underscores why the decline in underage drinking is genuinely consequential for long-term public health. Since 2015, there are 2.6 million fewer underage drinkers and more than 2.1 million fewer underage binge drinkers — a trend that, if sustained, should produce measurable reductions in adult AUD prevalence in the decades ahead. The flip side of the progress story: approximately 10.5% of all US children — roughly 7.5 million kids — live in a household with a parent who has an alcohol use disorder, experiencing elevated rates of trauma, neglect, and their own elevated risk of addiction throughout childhood and into adulthood.

Opioid Addiction Statistics in the US 2026

 OPIOID CRISIS BY THE NUMBERS — US 2023/2024
 ──────────────────────────────────────────────────────────────
  Opioid Use Disorder (2024)          █████░░░░░░░░░░░   4.8 Million
  Rx Opioid Misuse (past year, 2024)  ████░░░░░░░░░░░░   7.6 Million
  OD deaths involving ANY opioid (24) ████████████░░░░   54,743
  OD deaths — fentanyl/synthetics(23) ████████████████   ~72,776
  OD deaths — prescription opioids    ██░░░░░░░░░░░░░░   13,026 (2023)
  OD deaths — heroin (2023)           ░░░░░░░░░░░░░░░░    3,984
 ──────────────────────────────────────────────────────────────
  Source: SAMHSA 2024 NSDUH; NIDA; CDC WONDER; CDC NCHS

Source: NIDA Drug Overdose Death Facts and Figures (2024); CDC NCHS Drug Overdose Deaths Data Brief 2025; CDC Understanding the Opioid Overdose Epidemic 2025; SAMHSA 2024 NSDUH; Overdose Lifeline 2025

Since 1999, approximately 806,000 Americans have died of opioid overdoses — a death toll larger than the entire population of many mid-sized American cities, accumulated over 25 years of a crisis that has evolved through three distinct waves. The first wave (1990s–2010) was driven by the aggressive prescribing of legal opioids for pain management, pushing prescription opioid deaths from 3,442 in 1999 to a peak of 17,029 in 2017. The second wave (2010 onward) saw heroin deaths surge as people hooked on prescription opioids turned to cheaper street alternatives when prescriptions became harder to obtain. The third wave, still very much underway, is defined by illicitly manufactured fentanyl, which is 50–100 times more potent than morphine and has saturated the illegal drug supply so thoroughly that ~92% of all opioid overdose deaths in 2023 involved synthetic opioids.

The single most important data trend in the opioid space right now is the 34% decline in fentanyl-related overdose deaths in 2024 compared to 2023. This is unprecedented in the history of the opioid epidemic, and it reflects a convergence of factors: expanded availability of naloxone (the overdose reversal medication), wider access to medications for opioid use disorder (MOUD) like buprenorphine and methadone, harm reduction innovations like fentanyl test strips, and supply-side disruptions from law enforcement. But the structural vulnerability remains: with 4.8 million Americans living with opioid use disorder and 7.6 million misusing prescription opioids in the past year, the underlying addiction burden that drives demand for opioids has not shrunk at a pace that matches the improvement in overdose mortality. The pipeline to overdose death has been narrowed — it has not been closed.

Marijuana & Cannabis Addiction Statistics in the US 2026

 CANNABIS USE & DISORDER — US 2024 (Aged 12+)
 ──────────────────────────────────────────────────────────────
  Past-year marijuana users          ████████████████████  64.2M
  Past-month marijuana users         ████████████░░░░░░░░  ~49M+
  Marijuana use disorder             ████████░░░░░░░░░░░░  20.6M
  New marijuana users past year      ██░░░░░░░░░░░░░░░░░░   2.9M
  Daily new users (approx.)          █░░░░░░░░░░░░░░░░░░░   ~7,900/day
  Use increased across age groups    ─── Including 65+ ──────────────
 ──────────────────────────────────────────────────────────────
  Source: SAMHSA 2024 NSDUH; SAMHSA 2025 blog release

Source: SAMHSA 2024 NSDUH (released July 28, 2025); SAMHSA NSDUH Blog, July 2025; American Addiction Centers Alcohol and Drug Abuse Statistics 2025

The cannabis data from the 2024 NSDUH is striking in its scale. 64.2 million Americans used marijuana in the past year in 2024, up from 53.1 million in 2021 — an increase of more than 11 million users in just three years. The rate of increase has been driven by ongoing legalization across states, declining perceived risk, and expanding product availability in both legal and illegal markets. What makes this especially significant from a public health perspective is not the use rate alone, but the disorder rate sitting alongside it: 20.6 million Americans — roughly one in three past-year users — met criteria for marijuana use disorder in 2024. This is the highest single-substance disorder count of any drug in the country, surpassing even alcohol use disorder.

The “marijuana use disorder” designation reflects clinically significant impairment or distress — including inability to cut down use despite wanting to, continued use despite negative consequences, withdrawal symptoms, and tolerance development — all of which are documented phenomena in heavy cannabis users, particularly those who began using in adolescence or use high-potency products daily. The demographic breadth of the trend is notable: marijuana use increased across every age group in the 2024 NSDUH, including adults 65 and older — a population in whom cannabis use was essentially negligible a decade ago. Among young people under age 21, marijuana is now used more frequently than alcohol or tobacco/nicotine products, a historic reversal in substance use patterns among young Americans that carries significant implications for brain development, mental health, and addiction trajectories.

Stimulant & Methamphetamine Addiction Statistics in the US 2026

 STIMULANT USE & OVERDOSE — US 2023/2024
 ──────────────────────────────────────────────────────────────
  Cocaine users (past year, 2024)    ██░░░░░░░░░░░░░░░░░   4.3 Million
  CNS stimulant use disorder         ██░░░░░░░░░░░░░░░░░   4.3 Million
  Meth OD deaths (2023)              ██████████░░░░░░░░░  ~34,855
  Cocaine OD deaths (2023)           █████████░░░░░░░░░░   29,449
  Cocaine OD deaths (2019 vs. 2023)  Rise of ███████████    +85%
  OD deaths w/ both IMF + stimulant  ████████░░░░░░░░░░░   ~70% of meth ODs
 ──────────────────────────────────────────────────────────────
  Source: SAMHSA 2024 NSDUH; NIDA; CDC WONDER

Source: NIDA Drug Overdose Death Facts and Figures 2024; CDC NCHS Data Brief 2025; SAMHSA 2024 NSDUH; CDC Overdose Prevention About page, April 2026

The stimulant addiction data delivers one of the more alarming trend lines in the entire addiction landscape. Cocaine-involved overdose deaths rose 85% from 2019 to 2023, reaching 29,449 deaths — and this increase has virtually nothing to do with a surge in cocaine use itself. The driver is fentanyl contamination: illicitly manufactured fentanyl increasingly adulterates the cocaine, methamphetamine, and counterfeit pill supply, meaning people who intend to use stimulants are often unknowingly consuming a substance that is, in tiny quantities, lethal. Nearly 70% of stimulant-involved overdose deaths in 2023 also involved fentanyl — a statistic that represents a fundamental shift in how overdose risk is distributed across all illicit drug users, not just opioid users.

Methamphetamine-involved deaths rose from 5,716 in 2015 to approximately 34,855 in 2023 — a 500%+ increase over eight years, making methamphetamine the second-largest drug category by overdose death count after fentanyl. The 4.3 million Americans with CNS stimulant use disorder — a category encompassing methamphetamine, amphetamine, and prescription stimulant misuse — represent a population with limited pharmacological treatment options: unlike opioid use disorder, for which FDA-approved medications like buprenorphine and methadone exist, there are currently no FDA-approved medications specifically for methamphetamine or cocaine use disorder, making behavioral interventions the primary available treatment. This treatment gap adds urgency to the broader conversation about funding and research priorities in addiction medicine.

Addiction Treatment Gap Statistics in the US 2026

 TREATMENT GAP — WHO NEEDED VS. WHO RECEIVED CARE (2024)
 ──────────────────────────────────────────────────────────────
  People needing SUD treatment:    ████████████████████  52.9M+
  People who received it:          ████░░░░░░░░░░░░░░░░  10.2M (~20%)
  People who did NOT receive it:   ████████████████░░░░  ~80%

  Treatment gap by population:
  Adults with AMI who got MH care: ██████████░░░░░░░░░░   52.1%
  Adults with SMI who got MH care: ████████████████░░░░   70.8%
  Adults with AUD or DUD — NO Tx:  ████████████████░░░░  ~80%
 ──────────────────────────────────────────────────────────────
  Source: SAMHSA 2024 NSDUH; SAMHSA Blog, July 2025

Source: SAMHSA 2024 NSDUH (released July 28, 2025); SAMHSA Blog July 2025; SAMHSA 2026 SUD Treatment Month; CDC About Overdose Prevention April 2026; Journal of the American Medical Association / Ohio State University SUD Treatment Study 2024

The treatment gap is where the addiction crisis is most starkly exposed as a structural failure — not simply a personal one. 80% of people who needed substance use disorder treatment in 2024 did not receive it. This is not primarily because people are unwilling to be helped — the most cited barrier, “no perceived need,” is itself shaped by the same denial, stigma, and minimization that define addiction as a disorder. Research published in 2024 found that fewer than 3% of people with SUD who needed but did not receive treatment actually perceived an unmet need and sought care — a figure that makes the enormity of the awareness and stigma challenge clear. When people do not believe they have a problem, they do not seek help, and no amount of treatment infrastructure can bridge that gap without meeting people where they are.

For those who do recognize their need, systemic barriers remain substantial. Cost, lack of available providers, geographic inaccessibility, and insurance coverage gaps all function as filters that screen out exactly the people who most urgently need care — lower-income individuals, rural residents, people without stable housing, and people whose employers or families are not in a position to support time in treatment. The growth of telehealth for SUD treatment, tracked in the 2024 NSDUH for the first time, represents one of the most promising structural changes in the system — removing the transportation and scheduling barriers that historically kept millions of people from accessing even a basic assessment. Expanding medications for opioid use disorder (MOUD), particularly buprenorphine prescribed in primary care settings rather than requiring specialty addiction clinics, is another lever that research consistently identifies as high-impact and underutilized.

Note: If you or someone you know is struggling with addiction, the SAMHSA National Helpline is available 24/7, 365 days a year: 1-800-662-4357 (free, confidential, in English and Spanish).

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE